Not Signed In - European Medicines Agency recommends suspension of Hexavac vaccine
Sun, 25 Sep 2005 02:00 PM EST
... The European Medicines Agency (EMEA) is recommending as a precautionary measure the suspension of the marketing authorisation for Hexavac due to concerns about the long-term protection against hepatitis B. Hexavac is a vaccine for infants and children against diphtheria, tetanus, whooping cough (pertussis), hepatitis B virus, polio virus and Haemophilus influenzae type b... click link for more info. ...
Related Topics
- Vaccine
- Polio Vaccine & Cancer
- Polio Vaccine
- Polio Vaccine & Origin of HIV/AIDS
- Aluminum and Magnesium Hydroxide Oral Suspension
- Vaccine Side Effects
- MMR Vaccine & (Asceptic) Meningitis
- Smallpox Vaccine
- Chickenpox Vaccine
- Amoxicillin Oral Suspension
- Hepatitis A Vaccine
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis B Vaccine
- Pneumococcal Vaccine
- Dicloxacillin Suspension
- Anthrax Vaccine
- Rotavirus Vaccine & Intussusception
- Black Alder
- Carbetapentane, Phenylephrine, and Pyrilamine oral suspension
- Ciprofloxacin Suspension
email this page
print this page
bookmark this page
feedback on this page
